Consumer Product Sales Surge at J&J

2008-10-14 | 01:06

Double digit gains driven by Listerine and Neutrogena.

Johnson & Johnson announced today that worldwide consumer product sales jumped 13.1% to $4.1 billion for the third quarter. Growth from  operations accounted for 9.4% of the gain and a positive impact from currency added 3.7%. Domestic sales increased 11.2%, while international sales increased 14.7%; 8.1% from operations and 6.6% from currency.

Sales results reflect the strong performance of the U.S. launch of Zyrtec, an over-the-counter allergy treatment; Listerine antiseptic mouthrinse; international sales of baby care products; and the skin care lines of Neutrogena, Clean & Clear and Aveeno. Also contributing to growth were sales of Dabao, the leading moisturizer in China, which was acquired as part of the recently completed acquisition of Beijing Dabao Cosmetics Co., Ltd., a personal care products company.